Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors

Journal of Immunology

Volumn 162, Issue 2, 1999, Pages 1113-1119

  Tanghe, Audrey ^a   Lefêvre, Philippe ^a   Denis, Olivier ^a   D'Souza, Sushila ^a   Braibant, Martine ^a   Lozes, Evelyne ^a   Singh, Mahavir ^b   Montgomery, Donna ^c   Content, Jean ^a   Huygen, Kris ^a  

^a PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; DRUG RECEPTOR BINDING; HAPLOTYPE; IMMUNOGENICITY; MOLECULAR RECOGNITION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHOSPHATE TRANSPORT; PRIORITY JOURNAL; PROPHYLAXIS; TUBERCULOSIS; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ATP-BINDING CASSETTE TRANSPORTERS; BACTERIAL PROTEINS; BACTERIAL VACCINES; CROSS REACTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; INTERLEUKIN-2; LUNG; MICE; MICE, INBRED C57BL; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; PERIPLASMIC BINDING PROTEINS; PHOSPHATE-BINDING PROTEINS; PHOSPHATES; PLASMIDS; SPLEEN; TUBERCULOSIS; VACCINES, DNA;

EID: 0344197552     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Bloom, B. R. C., and C. J. L. Murray. 1992. Tuberculosis: commentary on a reemergent killer. Science 257:1055.
2. Bloom, B. R., and P. E. M. Fine. 1994 The BCG experience: implications for future vaccines against tuberculosis. In Tuberculosis: Pathogenesis, Protection and Control. B. R. Bloom, ed. ASM Press, Washington, p. 531.
3. Orme, I. M. 1997. Progress in the development of new vaccines against tuberculosis. Int. J. Tuberc. Lung Dis. 1:95.
4. Pelicic, V., J.-M. Reyrat, and B. Gicquel. 1998. Genetic advances for studying Mycobacterium tuberculosis pathogenicity. Mol. Microbiol. 28:413.
5. Andersen, P. 1994. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62:2536.
6. Horwitz, M. A., B. Lee, B. J. Dillon, and G. Harth. 1995. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 92:1530.
7. Wiker, H. G., and M. Harboe. 1992. The antigen 85 complex: A major secretion product of Mycobacterium tuberculosis. Microbiol. Rev. 56:648.
8. Huygen, K., J. Content, O. Denis, D. L. Montgomery, A. M. Yawman, R. R. Deck, C. M. DeWitt, I. M. Orme, S. Baldwin, C. D'Souza, et al. 1996. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2:893.
9. Sonnenberg, M. G., and J. T. Belisle. 1997. Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal ammo acid sequencing and electrospray mass spectrometry. Infect. Immun. 65:4515.
10. Andersen, P. 1997. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand. J. Immunol. 45:115.
11. Huygen, K., A. Drowart, M. Harboe, R. ten Berg, J. Cogniaux, and J. P. Van Vooren. 1993. Influence of genes from the major histocompatibility complex on the antibody repertoire against culture filtrate antigens in mice infected with live Mycobacterium bovis BCG. Infect. Immun. 61:2687.
12. Braibant, M., P. Lefevre, L. De Wit, P. Peirs, J. Ooms, K. Huygen, A. B. Andersen, and J. Content. 1996, A Mycobacterium tuberculosis gene cluster encoding a phosphate transporter, homologous to the Escherichia coli Pst system. Gene 176:171.
13. Braibant, M., P. Lefèvre, L. De Wit, R. Wattiez, and J Content. 1996. Identification of a second Mycobacterium tuberculosis gene cluster encoding proteins of an ABC phosphate transporter. FEBS Lett. 394:206.
14. Lefèvre, P., M. Braibant, L. De Wit, M. Kalai, D. Röeper, J. Grötzinger, J.-P. Delville, P. Peirs, J. Ooms, K. Huygen, and J. Content. 1997. Three different putative phosphate transport receptors are encoded by the Mycobacterium tuberculosis genome and are present at the surface of Mycobacterium bovis BCG. J. Bacterial 179:2900.
15. Andersen, A. B., L. Ljungqvist, and M. Olsen. 1990. Evidence that protein antigen b of M. tuberculosis is involved in phosphate metabolism. J. Gen. Microbiol. 136:477.
16. Andersen, A. B., and E. B. Hansen. 1989. Structure and mapping of antigenic domains of protein antigen b, a 38,000-molecular-weight protein of Mycobacterium tuberculosis. Infect. Immun. 57:2481.
17. Harboe, M., and H. G. Wiker. 1992. The 38-kDa protein of Mycobacterium tuberculosis: a review. J. Infect. Dis. 166:874.
18. Braibant, M., L. De Wit, P. Peirs, M. Kalai, J. Ooms, K. Huygen, and J. Content. 1994. Structure of the mycobacterial antigen 88: a protein related to the E. coli pstA periplasmic phosphate permease subunit. Infect. Immun. 62:849.
19. Bothamley, G. H., R. Rudd, F. Festenstein, and J. Ivanyi. 1992. Clinical value of the measurement of Mycobacterium tuberculosis specific antibody in pulmonar tuberculosis. Thorax 47:270.
20. Hasløv, K., A. B. Andersen, L. Ljungqvist, and M. W. Bentzon. 1990. Comparison of the immunological activity of five defined antigens from Mycobacterium tuberculosis in seven inbred guinea pig strains. Scand. J. Immunol. 31:503.
21. Vordermeier, H. M., D. P. Harris, E. Roman, R. Lathigra, C. Moreno, and J. Ivanyi. 1991. Identification of T cell stimulatory peptides from the 38-kDa protein of Mycobacterium tuberculosis. J. Immunol. 147:1023.
22. Vordermeier, H. M., D. P. Harris, G. Friscia, E. Roman, H.-M. Surcel, C. Moreno, G. Pasvol, and J. Ivanyi. 1992. T cell repertoire in tuberculosis: selective anergy to an immunodominant epitope of the 38 kD antigen in patients with active disease. Eur. J. Immunol. 147:2631.
23. Vordermeier, H. M., D. P. Harris, C. Moreno, M. Singh, and J. Ivanyi. 1995. The nature of the immunogen determines the specificity of antibodies and T cells to selected peptides of the 38 kDa mycobacterial antigen. Int. Immunol. 7:559.
24. Borremans, M., L. De Wit, G. Volckaert, J. Ooms, I. De Bruyn, K. Huygen, J. P. Van Vooren, M. Stelandre, R. Verhofstadt, and J. Content. 1989. Cloning, sequence determination, and expression of a 32-kilodalton-protein gene of Mycobacterium tuberculosis. Infect. Immun. 57:3123.
25. Montgomery, D. L., J. W. Shiver, K. R. Leander, H. C. Perry, A. Friedman, D. Martinez, J. B. Ulmer, J. J. Donnelly, and M. A. Liu. 1993. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol. 12:777.
26. Shiver, J. W., H. C. Perry, M. E. Davies, and M. A. Liu. 1995. Immune responses to HIV gp120 elicited by DNA vaccination. In Vaccines 95. R. M. Chanock, F. Brown, H. S. Ginsberg, and E. Norrby. eds. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. p. 95.
27. Huygen, K., D. Abramowicz, P. Vandenbussche, F. Jacobs, J. De Bruyn, A. Kentos, A. Drowart, J.-P. Van Vooren, and M. Goldman. 1992. Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice. Infect. Immun. 60:2880.
28. De Bruyn, J., K. Huygen, R. Bosnians, M. Fauville, R. Lippens, J.-P. Van Vooren, P. Falmagne, M. Weckx, H. G. Wiker, M. Harboe, and M. Turneer. 1987. Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG. Microb. Pathog. 2:351.
29. Singh, M., A. B. Andersen, J. E. G. Me Carthy, M. Rohde, H. Schütte, E. Sanders, and K. N. Timmis. 1992. The Mycobacterium tuberculosis 38 kD antigen: overproduction in Escherichia coli, purification and characterization. Gene 117:53.
30. Lozes, E., O. Denis, A. Drowart, F. Jurion, K. Palfliet, A. Vanonckelen, M. De Cock, J. P. Van Vooren, and K. Huygen. 1997. Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the Mais-group. Scand. J. Immunol. 46:16.
31. Huygen, K., E. Lozes, B. Gilles, A. Drowart, K. Palfliet, F. Jurion, I. Roland, M. Art, M. Dufaux, J. Nyabenda, J. De Bruyn, J. P. Vanvooren, and R. Deleys. 1994. Mapping of Th1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG. Infect. Immun. 62:363.
32. + T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect. Immun. 66:1527.
33. Donnelly, J. J., J. B. Ulmer, J. W. Shiver, and M. A. Liu. 1997. DNA vaccines. Annu. Rev. Immunol. 15:617.
34. Tighe, H., M. Corr, M. Roman, and E. Raz. 1998. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol. Today 19:89.
35. Robinson, H. L., H. S. Ginsberg, H. L. Davis, S. A. Johnston, and M. A. Liu. 1997. The Scientific Future of DNA for Immunization. American Academy of Microbiology ASM, Washington, DC. p. 19.
36. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. Role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249.
37. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, and B. R. Bloom. 1995. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561.
38. Huygen, K. 1998. DNA vaccines: application to tuberculosis. Int. J. Tuberc. Lung Dis. In press.
39. Huygen, K., K. Palfliet, F. Jurion, J. Hilgers, R. ten-Berg, J. P. Van-Vooren, and J. De-Bruyn. 1988. H-2-linked control of in vitro γ interferon production in response to a 32-kilodalton antigen (P32) of Mycobacterium bovis bacillus Calmette-Guerin. Infect. Immun. 56:3196.
40. Huygen, K., L. Ljungqvist, R. ten-Berg, and J. P. Van-Vooren. 1990. Repertoires of antibodies to culture filtrate antigens in different mouse strains infected with Mycobacterium bovis BCG. Infect. Immun. 58:2192.
41. Ellner, J. J. 1997. Review: the immune response in human tuberculosis-implications for tuberculosis control. J. Inject. Dis. 176:1351.
42. Palmer, C. E., and M. W. Long. 1966. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am. Rev. Resp. Dis. 94:553.
43. Fine, P. E. M. 1995. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339.
44. Tascon, R. E., M. J. Colston, S. Ragno, E. Stavropoulos, D. Gregory, and D. B. Lowrie. 1996. Vaccination against tuberculosis by DNA injection. Nat. Med. 2:888.
45. Zhu, X. J., N. Venkataprasad, H. S. Thangaraj, M. Hill, M. Singh, J. Ivanyi, and H. M. Vordermeier. 1997. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J. Immunol. 158:5921.
46. Klinman, D. M., A.-K. Yi, S. L. Beaucage, J. Konover, and A. M. Krieg. 1996. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete IL-6, 1L-12 and IFN-γ. Prof. Natl. Acad. Sci. USA 93:2879.